Barriers to Substance Use Disorder Recovery

Sponsor
Prisma Health-Upstate (Other)
Overall Status
Completed
CT.gov ID
NCT04098614
Collaborator
Clemson University (Other), University of South Carolina School of Medicine (Other)
99
1
2
15.5
6.4

Study Details

Study Description

Brief Summary

The study purpose is to investigate how an inpatient recovery coaching intervention can overcome or mitigate specific risk factors and barriers to initiating and maintaining Substance Use Disorder recovery. This study will offer insight into how and why an inpatient link to recovery coaching is effective for promoting long-term Substance Use Disorder recovery.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Recovery Coach Intervention
N/A

Detailed Description

Substance Use Disorder (SUD) is a prevalent disease that impacts an estimated 24 million Americans each year. The life-altering consequences of SUD are both diverse and severe, influencing mortality, the workplace, and economics. The goal of this study is to determine how specific risk factors of relapse and barriers to recovery, including neurocognitive, health, personal, social, financial, and situational barriers, can be overcome or changed through a recovery coaching intervention. This work seeks to provide a mechanism to demonstrate exactly how and why this potential new model of care (recovery coaching) is effective, rather than simply assessing if it can work. To accomplish this aim, the change between baseline and 6-month assessments will be assessed. Then, the difference in the change between individuals assigned to the current standard of care and patients assigned to inpatient recovery will be compared.

Study Design

Study Type:
Interventional
Actual Enrollment :
99 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The investigator/study personnel inform the participant regarding which arm they have been assigned and inform a recovery coach if the participant is randomized to the intervention arm.The investigator/study personnel inform the participant regarding which arm they have been assigned and inform a recovery coach if the participant is randomized to the intervention arm.
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Barriers to Substance Use Disorder Recovery
Actual Study Start Date :
Sep 3, 2019
Actual Primary Completion Date :
Dec 18, 2020
Actual Study Completion Date :
Dec 18, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Recovery Coach Intervention

Experimental: Recovery Coach Intervention Participants randomized to the intervention arm are linked to a recovery peer coach while they are in the hospital. Recovery peer coaches are provided to the participant by Faces and Voices of Recovery (FAVOR) - Greenville. Recovery coaches are Certified Peer Support Specialists (CPSS), individuals who have firsthand experience in successful recovery and are trained in using recovery-oriented tools to help peers overcome addiction. FAVOR offers immediate access to a personal coach, a local center, and assistance to off-site intervention and recovery resources in the community. They provide twice weekly contact with participants.

Behavioral: Recovery Coach Intervention
Participants randomized to the intervention arm are linked to a recovery peer coach while they are in the hospital. Recovery peer coaches are provided to the participant by Faces and Voices of Recovery (FAVOR) - Greenville. Recovery coaches are Certified Peer Support Specialists (CPSS), individuals who have firsthand experience in successful recovery and are trained in using recovery-oriented tools to help peers overcome addiction. FAVOR offers immediate access to a personal coach, a local center, and assistance to off-site intervention and recovery resources in the community. They provide twice weekly contact with participants.

No Intervention: Standard of Care Control

Patients in the control condition receive the current standard of care, which entails a treatment referral with a list of addiction recovery facilities, groups, and resources. It is the patient's responsibility to call a treatment facility or group on the list and thus relies on self-referral. The medical team is not permitted to call a facility or group on behalf of the patient. The physician may counsel the patient on the dangers of substance abuse and addiction, but the extent of counseling is variable and dependent on the individual physician.

Outcome Measures

Primary Outcome Measures

  1. Change in Social Support [intervals of 1, 2, 3, and 6 months post-baseline assessment]

    Participants will complete the 5-item Social Support subscale of the Assessment of Recovery Capital (ARC) to assess social support. The difference between the post-baseline and baseline measures will be assessed.

  2. Change in Financial Barriers to SUD Recovery [intervals of 1, 2, 3, and 6 months post-baseline assessment]

    These barriers include lack of stable housing, transportation, and cost of recovery services. Participants will complete the Housing and Safety Subscale of the Assessment of Recovery Capital (ARC) to assess social support and housing stability. The difference between the post-baseline and baseline measures will be assessed.

  3. Change in Situational Barriers to SUD Recovery [intervals of 1, 2, 3, and 6 months post-baseline assessment]

    The barriers measured will be (1) long delays for treatment, (2) complexity of navigating the healthcare system, (3) lack of programs in one's community, (4)lack of professional help, (4) and not knowing where to go for help. The response options are binary (yes, they think this is a barrier to their recovery', or 'no, not a barrier to recovery'). Responses to these questions (0=no, 1=yes) will be summed to determine situational barriers. The difference between the post-baseline and baseline measures will be assessed.

  4. Change in Inhibitory Control [baseline and 6 months post-baseline assessment]

    Inhibitory control will be assessed behaviorally using a 150 - 200 trial computerized 'Stop Signal' Task, the most common measure of this construct. Stop Signal Reaction Time (SSRT) and Stop trial accuracy will be measured and compared across time points.

  5. Change in Resting State EEG beta poewer [baseline and 6 months post-baseline assessment]

    We will measure both absolute and relative powers for beta (14-25 Hz) bands using a 24-channel Soterix Medical EEG.

  6. Change in Striatal Dopaminergic Functioning [baseline and 6 months post-baseline assessment]

    Consistent with previous research, we will assess average spontaneous eyeblink rate, a well-validated indirect proxy for available levels of striatal tonic dopamine.

  7. Change in Risk-Taking [baseline and 6 months post-baseline assessment]

    Risk-taking will be measured using the 7-item Risk Propensity Scale (Meertens & Lion, 2008). Higher scores on this scale indicate greater risk-taking propensity.

  8. Change in Emotion Regulation [baseline and 6 months post-baseline assessment]

    The Emotion Regulation Questionnaire (ERQ-10) will be used to assess these emotion regulation strategies and skills.

  9. Change in Goal-Related Activities [baseline and 6 months post-baseline assessment]

    Participants will complete the 5-item Meaningful Activities from the Assessment of Recovery Capital questionnaire. The 5 items will be summed for a total score.

Secondary Outcome Measures

  1. Engagement in Recovery Services [intervals of 1, 2, 3, and 6 months post-baseline assessment]

    Active involvement in recovery programs. This is a binary response question. Participants are asked "Are you actively involved in a recovery program right now?". Response options are 'yes' or 'no'. We will measure the change over time in engagement for each participant and compare the percentage of those in the intervention and control arm that are actively involved in recovery services at each time point.

  2. Hospital Visit Frequency [six months pre- and post-baseline assessment]

    number of readmissions and number of emergency department visits

  3. Substance Use Severity [intervals of 1, 2, 3, and 6 months post-baseline assessment]

    Frequency of substance use in past 30 days measured using the Addiction Severity Index (ASI-Lite).

  4. Emotional Well-being [intervals of 1, 2, 3, and 6 months post-baseline assessment]

    Participants will be asked to self-report two items about their emotion well-being on a scale of 0 (Not at all) to 9 (Severely). The questions are "In the past 30 days, how much have you been bothered by feeling sad, down, or uninterested in life?" and "In the past 30-days, have you felt anxious or nervous?".

  5. Life Satisfaction [intervals of 1, 2, 3, and 6 months post-baseline assessment]

    Participants will be asked to self-report their life satisfaction using a single item question on a scale of 1 (Very Satisfied) to 4 (Very Dissatisfied). Change across time on this scale will be measured.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 18 - 60

  • English speaking;

  • Identified by healthcare provider as having Substance Use Disorder

  • Recent substance use

  • Currently admitted to the Medical Teaching Services, general medicine hospitalist services, or Infectious Disease Consult service at Greenville Memorial Hospital

Exclusion Criteria:
  • Are unable to provide informed consent (intubation, confusion, etc.) during hospitalization

  • Are admitted for marijuana use only

  • Are admitted for cocaine use only

  • Are pregnant

Contacts and Locations

Locations

Site City State Country Postal Code
1 Greenville Memorial Hospital Greenville South Carolina United States 29605

Sponsors and Collaborators

  • Prisma Health-Upstate
  • Clemson University
  • University of South Carolina School of Medicine

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Prerana Roth, Clinical Assistant Professor, Prisma Health-Upstate
ClinicalTrials.gov Identifier:
NCT04098614
Other Study ID Numbers:
  • Pro00087080
First Posted:
Sep 23, 2019
Last Update Posted:
Feb 25, 2021
Last Verified:
Feb 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Prerana Roth, Clinical Assistant Professor, Prisma Health-Upstate
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 25, 2021